BRIAN GHEZELAIAGH: Open Payments
NPI 1033616206 · STONY BROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 58 payments from 9 companies in 2025. Trend: 2023 $168 · 2024 $1,362 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $266 |
| Otsuka America Pharmaceutical, Inc. | 12 | $205 |
| Corium, LLC | 14 | $160 |
| ABBVIE INC. | 6 | $149 |
| Vanda Pharmaceuticals Inc. | 7 | $139 |
| Janssen Pharmaceuticals, Inc | 5 | $120 |
| Lundbeck LLC | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Auvelity, REXULTI, Azstarys, VRAYLAR, SPRAVATO, FANAPT, HETLIOZ, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
